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Abstract. The susceptibility status of field-collected Aedes aegypti (L.) from a dengue
endemic area to Bacillus thuringiensis israelensis (Bti) and temephos was determined.
Since August 2007, biweekly ovitrap surveillance (OS) was conducted for 12 mo in 2
sites, A & B, in Shah Alam, Selangor. Site A was treated with a Bti formulation, VectoBac®
WG at 500 g/ha, from December 2007 – June 2008 while Site B was subjected to routine
dengue vector control activities conducted by the local municipality. Aedes aegypti larvae
collected from OS in both sites were bred until F3 and evaluated for their susceptibility.
The larvae were pooled according to 3 time periods, which corresponded to Bti treatment
phases in site A: August – November 2007 (Bti pre-treatment phase); December 2007 –
June 2008 (Bti treatment phase); and July – September 2008 (Bti post-treatment phase).
Larvae were bioassayed against Bti or temephos in accordance with WHO standard
methods. Larvae collected from Site A was resistant to temephos, while incipient
temephos resistant was detected in Site B throughout the study using WHO diagnostic
dosage of 0.02 mg/L. The LC50 of temephos ranged between 0.007040 – 0.03799 mg/L
throughout the year in both sites. Resistance ratios (LC50) indicated that temephos
resistance increased with time, from 1.2 – 6.7 folds. The LC50 of Ae. aegypti larvae to
Bti ranged between 0.08890 – 0.1814 mg/L throughout the year in both sites, showing
uniform susceptibility of field larvae to Bti, in spite of Site A receiving 18 Bti treatments
over a period of 7 mo. No cross-resistance of Ae. aegypti larvae from temephos to Bti
was detected.
INTRODUCTION
Dengue fever (DF) and dengue
haemorrhagic fever (DHF) are the most
significant vector-borne viral diseases
globally. The causative dengue virus, a
flavivirus, is principally transmitted by the
Aedes spp. mosquitoes. The virus has four
antigenically similar but immunologically
distinct serotypes. In the absence of an
effective vaccine, vector control is the only
method to prevent transmission of this viral
disease. Unfortunately, insecticide
resistance has continued to spread and
affect disease control programmes in many
countries (WHO, 1980).
The current strategy of the Vector
Borne Disease Control Programme
(VBDCP) in Malaysia against dengue is
source reduction, larviciding and
adulticiding in outbreak sites. Fogging with
insecticides is conducted within a radius of
200 – 400 m of a reported dengue case, and
repeat fogging is conducted within 7 – 10 d
after the first fogging (Lee et al., 2008).
Adulticides that are commonly used in
mosquito control programme are
pyrethroids, while temephos is
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recommended as the larvicide (Ang &
Satwant, 2001; Lee et al., 2008). In spite of
fogging in the infected area and the latest
guidelines on treatment, dengue remains a
major public health problem. The lack of
community awareness and information on
the field dengue vector susceptibility
status to the commonly used insecticides
have impeded the success of dengue
vector control programme. Therefore,
examination on susceptibility status of
field populations of Aedes spp. larvae and
adults from the dengue endemic areas to
insecticides that are commonly used in
mosquito control is important.
The principal larvicide used in the
control of dengue vectors is temephos
(Abate®). In Malaysia, it has been used
since the first DF outbreak in 1973. It is
added in potable containers as 1% (w/w)
sand granules to control breeding in
stagnant waters (Cheong, 1978). This
formulation is available as 100 gram
sachets for consumer purchase and it is
also distributed by the local authorities to
residents from dengue infected premises.
The 30 years of temephos use warrants an
investigation into the susceptibility status
of the dengue vector larvae to be constantly
carried out.
Bacillus thuringiensis israelensis
(Bti) was used to replace temephos in
dengue epidemic countries with temephos
resistance. Bti is the predominant
biological control agent applied in the
mosquito control programme in the United
States, Asia and Europe (Becker, 2004).
The effectiveness of its larvicidal activity
has been well-documented since its
introduction more than 20 years ago and the
development of resistance to Bti in the field
population to all mosquito species has not
been reported (Lacey, 2007).  In this study,
the state of Selangor was chosen as the
study site due to continuous high incidences
of dengue reported in the recent years. In
2007, 15,871 of 48,846 total dengue cases
were reported in this state; 21,262 of 49,335
and 18,676 of 41,486 dengue cases were
reported respectively in 2008 and 2009
(Ministry of Health, Malaysia, 2009; 2010).
The state capital of Selangor, Shah Alam,
was identified by the local authority as one
of the areas in Selangor with high number
of dengue cases. In the early 2009, 14
dengue hot spots were identified in Shah
Alam (Salina, 2009). Temephos was the
only larvicide used by the residents in this
area. During the one-year ovitrap
surveillance, Bti treatment (500g/ha) was
conducted simultaneously for 7 mo from
December 2007 – June 2008 in this area.
The objective of this study was to monitor
both temephos and Bti susceptibility in the
field dengue vector population for a year.
MATERIALS AND METHODS
Study Period
August 2007 – September 2008
Study Site: Section 17, Shah Alam,
approximately 50 km from Kuala Lumpur
City Centre. Two designated sites were
chosen in this area: Site A (8 ha) with 300
houses; and Site B (10 ha) with 400 houses.
Both of the residential areas had rows of
double storey terrace houses or clusters of
4 houses.  The distance between 2 rows of
houses was approximately 10 m. The front
yard designed as a garden (approximately
18 m2) was common in most of the houses.
Artificial ponds and aquaria were observed
in several houses at both sites at the front
yard. Back yard space is limited, thus
vegetation was hardly found. Discarded
garbage was thrown at the back lane.
Covered drums for water storage purpose
were also found at the back lane. The local
authority at Site B carried out adulticiding
when dengue cases were reported during
the study period. Bti treatment (500 g/ha)
was conducted simultaneously for 7 mo
from December 2007 – June 2008 in Site A.
The Bti treatment was carried out at
biweekly basis in the Bti-treatment phase.
After 7 times of biweekly Bti treatments,
adjustment was made from biweekly to
weekly Bti-treatment for 7 Bti treatments.
After that, biweekly Bti treatment was re-
implemented for 4 times until the Bti-
treatment phase was completed.
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Ovitrap Surveillance (OS)
The gravid mosquito adult population was
monitored by using ovitraps as described
by Lee (1992). The ovitrap consisted of a
300 mL plastic container with straight,
slightly tapered sides. The container
exterior was coated with a layer of black
oil paint. Each ovitrap was filled with
approximately 200 mL seasoned tap water
and a hardboard paddle (10.0 x 2.5 x 0.3
cm) was placed in the water with the rough
surface upwards. The paddle served as an
oviposition substrate for the female
mosquitoes.
A total of 60 ovitraps were placed
indoors and outdoors in 30 randomly
selected houses in each site. OS was
conducted twice a month, the first and third
week of the month. All ovitraps were
collected after five days and brought to the
Medical Entomology Unit, Institute for
Medical Research (IMR).
In the laboratory, the ovitrap contents
including the paddles were transferred into
respective plastic containers filled with
seasoned fresh water. Sufficient quantity of
water was then added to ensure the paddle
was fully submerged. A piece of half-
cooked beef liver was added into each
container as larval food. The containers
were covered to prevent wild mosquitoes
from ovipositing and were left in the
laboratory for 7 days. The hatched larvae
were identified and counted on the 3rd day
post collection. Only mosquito larvae of 3rd
instar and beyond were picked and
accounted for during the count. Larval
counting was subsequently carried out
every alternate day until day 7 post
collection, thus providing sufficient time for
all eggs to hatch. Only Aedes aegypti
mosquitoes were kept for further analysis.
The larvae were pooled and bred until F3
and evaluated for temephos and Bti
susceptibility in accordance to three time
frames intervals which corresponded to the
pre-treatment of Bti (August – November
2007), treatment of Bti (December 2007 –
June 2008) and post-treatment application
of Bti (July – September 2008).
Larval Bioassays
Temephos
This test was conducted according to WHO
(1981) larval susceptibility bioassay.
Disposable paper cups of 300 mL capacity
were used in the bioassays. Tests were run
at 6 series concentrations of 3 replicates.
Stock solution of 5000 mg/L temephos was
prepared in ethanol and further diluted to
50 mg/L. One hundred mL of seasoned tap
water was added into each test cups. The
cups were left for 30 min after pipetting the
required volume of insecticide into them.
After that, twenty-five 3rd instar larvae
were introduced into each cup and 150 mL
water was further added to make up the
final volume to 250 mL. Larval mortality
was recorded after 24 hours post exposure.
Control cups received only 1 mL ethanol.
To determine temephos resistance of field
larvae, the diagnostic dosage (DD) was
used. According to WHO standard (WHO,
1981), the temephos DD for Ae. aegypti is
0.02 mg/L. The technical grade (94.5%) of
temephos used in the study was provided
by BASF Co., Malaysia.
Bacillus thuringiensis israelensis(Bti)
Bti susceptibility testing was conducted in
accordance to an Institute for Medical
Research (IMR) protocol [(IMR/IDRC/
ENTO/SOP/01, 2002, unpublished)]. Each
test consisted of 6 different concentrations
of three replicates. A commercial
formulation, VectoBac® WG (Lot 155-563-
PG) manufactured by Valent BioSciences
Corporation, USA was used. Stock solution
of Bti was prepared in distilled water.
Primary stock prepared was 100000 mg/L
and a serial dilution was prepared to make
up a final stock of 100 mg/L. Assays were
conducted in disposable paper cups which
held 200 mL test volume. Batches of 25 late
3rd instar larvae were introduced in 50 mL
distilled water. Bti dilutions were prepared
by dispensing the required volume from the
working concentrations followed by
addition of the remaining water volume to
make the total volume of 150 mL. Larval
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mortality was recorded after 24 hours post
exposure. Control cups were not treated
with Bti.
Bioassay of Bti and temephos against
laboratory strain of Aedes aegypti
The lab strain of Ae. aegypti obtained from
insectary of IMR, has been established for
more than a thousand generation. This
lab strain was used as a reference because
it is not exposed to any insecticide since
it was established. F1018 and F1020
generations were used for assays
conducted on different months. The
procedure of susceptibility testing of Bti
and temephos against laboratory strain
of Ae. aegypti was similar to the field
strain Ae. aegypti susceptibility testing
mentioned above. Each bioassay series
involved 6 concentrations of 3 replicates
with 25 larvae in each cup. A range of
concentrations inducing mortality between
10 – 90% was used to determine the LC
(lethal concentration) values.
Data Analysis
Mortality was recorded after 24 h exposure
and subjected to probit analysis using the
statistics software SPSS (version 11.5). Only
concentrations causing between 10 – 90%
mortality were included in the analysis.
Based on the computed LC50 & LC90 values,
the resistance ratios, RR50 & RR90 of
temephos and Bti were determined. The
resistance ratio (RR) was determined by
comparison with the LC50/LC90 values of
field Ae. aegypti and the susceptible
laboratory strain Ae. aegypti. Mean of the
LC50 and LC90 values for laboratory strain
obtained from the 2 generations mentioned
above was calculated and used in the RR
formulation.
Determination of RR for Bti:
RR50/90 = LC50/90 field Ae. aegypti
LC50/90 laboratory strain Ae. aegypti
Determination of RR for temephos:
RR50/90 = LC50/90 field Ae. aegypti
LC50/90 laboratory strain Ae. aegypti
Temephos resistance/susceptibility status
of mosquito was evaluated according to
WHO interpretation (WHO, 1998): larval
mortality > 98% = temephos susceptible;
mortality < 80% = temephos resistance; and
mortality in the range of 80% - 98% defines
possibility of resistance that needs further
confirmation.
RESULTS
The Bti susceptibility of the field Ae.
aegypti was determined over a year and
categorized into three time frames: first 3
mo (August – November 07);  subsequent
7 mo (December 07 – June 08); and final 3
mo (July – September 08). This time frame
was used for the purpose of correlating the
susceptibility trend to Bti after introduction
of Bti treatments in site A.
Temephos susceptibility trend was also
determined to the above mentioned time
frames where the larvae were pooled
within each time frame. This was done due
to insufficient field population, because in
Site A dengue vector population was very
much reduced due to Bti treatments and
also in Site B due to adulticiding conducted
by health authorities for 2 mo (May – June
08) because of dengue outbreaks.
Bti susceptibility
Susceptibility of field Ae. aegpti larvae to
Bti is shown in Table 1. Both generations
of the lab strain Ae. aegypti from IMR were
highly susceptible to Bti with mean LC50 of
0.04002 mg/L. Field larvae from Site A (Bti
treated site) were susceptible to Bti at pre-
treatment phase, with LC50 of 0.1226 mg/L
(RR50 3.1 folds) followed by 0.1156 mg/L
with (RR50 2.9 folds) at Bti-treatment
phase. There was a slight decrease in
susceptibility of field larvae in Site A with
LC50 of 0.1814 mg/L (RR50 4.5 folds) at post-
treatment phase. In general, field larvae
from Site A were susceptible to Bti
throughout the three phases. From August
– November 07, LC50 for Site B was 0.09221
mg/L (RR50 2.3 folds). For the following
months, from December 07 – June 08 and
July – September 08, respectively, the LC50
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Table 1. Susceptibility of laboratory-bred and field Ae. aegypti to Bti
LC50 (mg/L) RR50 LC90 (mg/L) RR90
(95% C.L.) (95% C.L.)
Lab Strain
F1018 0.04088 – 0.06274 –
(0.03786–0.04622) (0.05333–0.08469)
F1020 0.03916 – 0.1150 –
(0.03558–0.04247) (0.09987–0.1418)
Mean ± S.E. 0.04002 ± 0.00 0.08887 ± 0.03
August – November 07
Site A
(Bti Pre-treatment Phase) 0.1226 3.1 0.2531 2.9
(0.1142–0.1323) (0.2221–0.3008)
Site B 0.09221 2.3 0.1798 2.0
(0.07774–0.1208) (0.1323–0.4251)
December 07 – June 08
Site A
(Bti Treatment Phase) 0.1156 2.9 0.2519 2.8
(0.1042–0.1284) (0.2150–0.3134)
Site B 0.1329 3.3 0.3091 3.5
(0.1008–0.1683) (0.2221–0.8361)
July – September 08
Site A
(Bti Post-treatment Phase) 0.1814 4.5 0.3527 4.0
(0.1665–0.1965) (0.3060–0.3983)
Site B 0.08890 2.2 0.1946 2.2
(0.08318–0.09512) (0.1732–0.2255)
was 0.1329 mg/L (RR50 3.3 folds) and
0.08890 mg/L (RR50 2.2 folds). Overall, field
larvae from Site B were susceptible to Bti
in the three time frames.
Temephos susceptibility
Both lab strains of Ae. aegypti from IMR
were highly susceptible to temephos with
mean LC50 of 0.005690 mg/L (Table 2).
Susceptibility to temephos from August –
November 07 was at LC50 of 0.007910 mg/
L at Site A (RR50 1.4 folds) followed by
0.02088 mg/L (RR50 of 3.7 folds) from
December 07 – June 08 and LC50 of 0.03799
mg/L (RR50 6.7 folds) from July –
September 08. At Site B, LC50 was 0.007040
mg/L (RR50 1.2 folds) from August –
November 07, followed by 0.01022 mg/L
(RR50 1.8 folds) and 0.01485 mg/L (RR50 2.6
folds), from December 07 – June 08
and July – September 08, respectively.
Decreased susceptibility of field Ae.
aegypti to temephos was observed in both
sites. The field larvae showed variations in
susceptibility when subjected to diagnostic
dosage (Table 3). According to WHO
interpretation (WHO, 1998), incipient
resistance was observed in Site A (88%)
from August – November 07 and resistance
was accounted for the subsequent months
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Table 3. Resistance status of field Ae. aegypti to temephos diagnostic
dosage (0.02 mg/L)
% Mortality
Site A Site B
August – November 07 88 100
December 07 – June 08 44 91
July – September 08 11 67
Control (IMR susceptible strain F 1018 & 1020) 100
Table 2. Susceptibility of lab-bred and field Ae. aegypti to temephos
LC50 (mg/L) RR50 LC90 (mg/L) RR90
(95% C.L.) (95% C.L.)
Lab Strain
F1018 0.006600 – 0.008130 –
(0.006310–0.006890) (0.007730–0.008700)
F1020 0.004780 – 0.009040 –
(0.003600–0.005380) (0.007920–0.01254)
Mean ± S.E 0.005690 ± 0.00 0.008585 ± 0.00
August – November 07
Site A 0.007910 1.4 0.02471 2.9
(0.006110–0.009740) (0.01798–0.04591)
Site B 0.007040 1.2 0.01552 1.8
(0.005650–0.008130) (0.01271–0.02309)
December 07 – June 08
Site A 0.02088 3.7 0.03924 4.6
(0.01930–0.02265) (0.03467–0.04633)
Site B 0.01022 1.8 0.01668 1.9
(0.009130–0.01120) (0.01501–0.01932)
July – September 08
Site A 0.03799 6.7 0.07058 8.2
(0.02801–0.04792) (0.05404–0.15804)
Site B 0.01485 2.6 0.02791 3.3
(0.01075–0.02016) (0.02043–0.1092)
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(44% and 11%). However, in Site B, the
population was susceptible to temephos
from August – November 07 (100%), and
showed mortality levels indicating
insipient resistance and resistant from
December 07 – June 08 and July –
September 08 respectively (91% and 67%).
Complete mortality was observed for lab
strain Ae. aegypti.
DISCUSSION
The development of insecticide resistance
remains the main obstacle in the mosquito
control programme. In this study, Bti
treatment was intensively applied for 7 mo
in Section 17, Shah Alam. Prior to this, Bti
was never used in vector control in this
area. According to the local authority, sand
granule temephos was the only larvicide
used in the area and distributed to the
residents to be applied in their premises.
In general, field mosquitoes were
highly susceptible to Bti throughout the
three time frames. Application of Bti did not
alter the Bti susceptibility of field Ae.
aegypti larvae at the treatment and post-
treatment phases as the RR50 remained at
2.9 – 4.5 folds in Bti treated site (Site A).
The result was similar to the study in
Alabama and Florida. Liu et al. (2004)
indicated that Culex quinquefasciatus Say
larvae were highly susceptible to Bti
although the larvae had been extensively
exposed to Bti. In Germany, after 10 years
of Bti application in mosquito control
programme by the German Mosquito
Control Association (KABS) to suppress
Aedes vexans, the population in the Bti
treated area remained susceptible to Bti
when compared to the untreated area
(Becker and Ludwig, 1993). In 2008, Lee et
al. conducted space spray application in a
suburban residential area and in a
temporary settlement site in the state of
Selangor, Malaysia. The wide area spray
application gave good significant reduction
in both Ae. aegypti and Aedes albopictus
populations.  In Cambodia, Bti was applied
into portable cement water jars holding rain
or river or well waters. Water dispersible
granule and tablet formulations of Bti were
introduced into the jars and the efficacy and
persistence in the treated jars were
observed until 12 wk post-treatment in the
treated jars. Large scale commune studies
in Cambodia for 2 consecutive years
showed that a single application of Bti in
all ‘in use’ containers controlled the adult
Ae aegypti population for 10 - 12 wk post
treatment (Setha et al., 2007). In Columbia,
Armengol et al. (2006) also showed that a
tablet formulation of Bti had reduced pupae
formation by more than 80% in the artificial
container for 12 wk. In Nuevo León State,
Mexico, the dengue control programme had
applied VectoBac® 12AS, a Bti liquid
formulation into the 200-gal metal water
drums. Larval indices were reduced to zero
in the 2-week treatment period (Ponce et
al., 2002). In India, Sharma et al. (2008) had
evaluated the persistence of Bti in a heavy
breeding site of Anopheles sp. and Culex sp.
by applying Bti into different habitats.
Application of Bti at 0.5 ml/m2 had
significantly reduced the density of
anophelines in clear water for 2 wk; and
double the dosage at 1.0 ml/m2 managed to
control breeding of Cx. quiquefasciatus in
polluted waters for 2 wk intervals.
When the field larvae were tested
against temephos, the results indicated that
some degree of resistance had developed
in field strain Ae. aegypti. RR50 increased
1.8 folds in Site A, as well as in Site B
where RR50 has increased to 1.4 folds from
July – September 08 when compared to
December 07 – June 08. Decreased
susceptibility of field Ae. aegypti to
temephos was observed in both Site A and
Site B. This was evaluated by conducting
bioassays at the temephos diagnostic
dosage. The populations in Site A and Site
B were subjected to temephos diagnostic
dosage, 0.02 mg/L. Survival of any Ae.
aegypti larvae from exposure to 0.02 mg/L
would indicate the possibility of resistance
among population tested. Results in
Table 3 showed 88% mortality from August
– November 07, 44% mortality from
December 07 – June 08 and subsequently
11% mortality from July – September 08 in
Site A, confirming the level of resistance
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among populations of Ae. aegypti. Similar
trend of susceptibility reduction was
observed in Site B, with 100% mortality
from August – November 07, 91% mortality
from December 07 – June 08 and 67%
mortality from July – September 08.
Resistance appeared to exist in the
population since pre-treatment in Site A.
WHO (1998) has categorized 80 – 97%
mortality in a susceptibility testing as the
possibility of resistance that needs to be
confirmed. The results in the diagnostic
dosage tested in the subsequent phases
have provided evidence of resistance
development in Site A.  Although temephos
resistance was detected in both sites,
however, susceptibility to Bti was not
affected. In a cross-resistance study
conducted by WHO (1979), temephos-
selected Cx. quinquefasciatus larvae were
susceptible to Bti, again indicating
chemical resistant population remained
susceptible to Bti.
Resistance of field mosquitoes in the
study area was unknown. Inheritance of
resistance could be the reason for the
occurrence of chemical resistance (Coker,
1958). The possibility of long-term
application of temephos in mosquito
control contributing to chemical resistance
was considered. In the first evaluation of
temephos susceptibility to field strain Ae.
aegypti collected from Kuala Lumpur in
1984, the results showed that while the
field larvae exhibited tolerance to
temephos, resistance was not detected (Lee
et al., 1984). The re-evaluation of the
susceptibility of Ae. aegypti to temephos at
various dosages was conducted by Lee &
Lime (1989) who showed that field larvae
from Jinjang, Kuala Lumpur, the location
where first dengue outbreak occurred in
1973-74, had low levels of resistance to
temephos. However, temephos was still
effective under operational dosage of 1 mg/
L. Similar  finding was observed by Chen
et al. (2005) who reported that although the
field Ae. aegypti exhibited resistance to the
diagnostic dosage (0.012 mg/L), complete
mortality to operational dosage at 1 mg/L
was observed. In the international realm,
the first nationally integrated programme
to monitor resistance status was the
Brazilian Health Foundation (FUNASA) in
1999, where field-collected larvae of Ae.
aegypti exhibited resistance to temephos in
most of the municipalities in the state of
Rio de Janeiro and Espírito Santo. These
2 states were intensively exposed to
temephos, fenitrothion and malathion since
1986 in the Brazilian Dengue Control
Programme (Lima et al., 2003). Another
study conducted in both the 2 states in
2001, indicated the populations had
resistance to temephos compared to those
of 2 years earlier (Braga et al., 2004).
Similar findings were obtained in the study
conducted in the Caribbean area and in
neighboring countries where temephos was
used for Ae. aegypti control for more than
10 years in the regions (Georghiou et al.,
1987; Rawlins & Joseph, 1995). Temephos
resistance also was reported in other Latin
America countries. The highest resistance
ratio (RR50) was found in Havana City with
100 folds higher than susceptible strain,
followed by Costa Rica (80 folds) and
Jamaica (50 folds), (Rodríguez et al.,
2007). In Thailand, resistance to temephos
was detected in high dengue endemic
districts where temephos was applied as
the larvicide in vector control programme
(Jirakanjanakit et al., 2007). Aedes
mosquitoes collected in 5 subdistricts in
Thailand exhibited different degrees of
resistance to temephos (Ponlawat et al.,
2005). In Argentina, field larvae exhibited
incipient resistance to temephos three
years later with resistance ratio increased
from 1.30 folds in the year 2004 to 3.10
folds in 2007 (Seccacini et al., 2008).
In conclusion, the data obtained
provided information on the susceptibility
status of Ae. aegypti in Shah Alam.
Temephos resistant was detected in Site A,
while incipient resistant was detected in
Site B. Microbial insecticides may be
important for mosquito control especially
in situations when local strains are
resistant to other chemical insecticides.
Therefore, it is important to alternate
temephos with other larvicides, such as
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Bacillus thuringiensis israelensis so as to
maximize the outcome of dengue control
programme.
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